Although one study has shown that Metrnl suppresses inflammatory responses by activating PPARγ [19], its role in RA has not yet been investigated, and it remains unclear whether any potential benefits in RA would indeed be PPARγ-dependent. The gene discussed is PPARG; the disease is rheumatoid arthritis.